Sol-Gel Technologies Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0011417206
USD
72.97
-8.23 (-10.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Assembly Biosciences, Inc.
Sol-Gel Technologies Ltd.
Societal CDMO, Inc.
Clearside Biomedical, Inc.
SELLAS Life Sciences Group, Inc.
Rezolute, Inc.
Minerva Neurosciences, Inc.
MEI Pharma, Inc.
Kineta, Inc.
Ampio Pharmaceuticals, Inc.
SciSparc Ltd.

Why is Sol-Gel Technologies Ltd. ?

1
Poor Management Efficiency with a low ROE of 0.67%
  • The company has been able to generate a Return on Equity (avg) of 0.67% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 12.07% over the last 5 years
3
Positive results in Sep 25
  • NET SALES(HY) Higher at USD 17.66 MM
  • NET PROFIT(HY) Higher at USD 5.67 MM
  • RAW MATERIAL COST(Y) Fallen by 0% (YoY)
4
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 1203.04%, its profits have risen by 6.1%
5
High Institutional Holdings at 42.56%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
  • Their stake has increased by 8.71% over the previous quarter.
6
Market Beating performance in long term as well as near term
  • Along with generating 1203.04% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Sol-Gel Technologies Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sol-Gel Technologies Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Sol-Gel Technologies Ltd.
1203.04%
18.01
520.49%
S&P 500
14.9%
0.77
19.29%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
12.07%
EBIT Growth (5y)
10.72%
EBIT to Interest (avg)
-17.36
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.82
Sales to Capital Employed (avg)
0.31
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
33.85%
ROCE (avg)
0.98%
ROE (avg)
0.67%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.14
EV to EBIT
-18.72
EV to EBITDA
-18.72
EV to Capital Employed
33.72
EV to Sales
10.09
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-180.10%
ROE (Latest)
-34.52%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
NET SALES(HY)

Higher at USD 17.66 MM

NET PROFIT(HY)

Higher at USD 5.67 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-8What is not working for the Company
PRE-TAX PROFIT(Q)

At USD -5.94 MM has Fallen at -597.01%

NET PROFIT(Q)

At USD -5.94 MM has Fallen at -597.01%

CASH AND EQV(HY)

Lowest at USD 45.13 MM

DEBT-EQUITY RATIO (HY)

Highest at -75.91 %

Here's what is working for Sol-Gel Technologies Ltd.

Net Sales
At USD 17.66 MM has Grown at 63.62%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Net Sales
Higher at USD 17.66 MM
than preceding 12 month period ended Sep 2025
MOJO Watch
In the half year the company has already crossed sales of the previous twelve months

Net Sales (USD MM)

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Sol-Gel Technologies Ltd.

Pre-Tax Profit
At USD -5.94 MM has Fallen at -597.01%
over average net sales of the previous four periods of USD -0.85 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -5.94 MM has Fallen at -597.01%
over average net sales of the previous four periods of USD -0.85 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Cash and Eqv
Lowest at USD 45.13 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at -75.91 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio